Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Invitrogen™ CD170 (Siglec F) Monoclonal Antibody (1RNM44N), Brilliant Violet™ 605, eBioscience™, Invitrogen™
GREENER_CHOICE

Catalog No. 406170282
Encompass_Preferred
Change view
Click to view available options
Quantity:
100 μg
25 μg
2 product options available for selection
Product selection table with 2 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
40-617-0282 100 μg
40-617-0280 25 μg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 2 options available.
2 options
Catalog No. 40-617-0282 Supplier Invitrogen™ Supplier No. 406170282
Add to Cart
Edge
Add to Cart

Rat Monoclonal Antibody

SIGLEC-F is a sialic acid-binding immunoglobulin-like lectin predominantly expressed on eosinophils in mice, where it serves as a functional paralog of human SIGLEC-8. It acts as an inhibitory receptor with ITIM motifs that recognize sialylated glycans and can induce eosinophil apoptosis, thereby helping regulate allergic inflammation and immune homeostasis.
TRUSTED_SUSTAINABILITY

Specifications

Antigen CD170 (Siglec F)
Applications Flow Cytometry
Classification Monoclonal
Clone 1RNM44N
Concentration 0.2 mg/mL
Conjugate Brilliant Violet 605
Formulation PBS with BSA and 0.09% sodium azide; pH 7.2
Gene Siglecf
Gene Accession No. Q920G3
Gene Alias SIGLEC-8
Gene Symbols Siglecf
Host Species Rat
Purification Method Affinity chromatography
Quantity 100 μg
Regulatory Status RUO
Primary or Secondary Primary
Gene ID (Entrez) 233186
Target Species Mouse
Content And Storage 4°C, store in dark, DO NOT FREEZE!
Product Type Antibody
Form Liquid
Isotype IgG2a κ
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.